CME Group Q4 25 Earnings Conference Call At 8:30 AM ET

CME Group will host a conference call at 8:30 AM ET on February 4, 2026 to discuss fourth-quarter 2025 earnings, with a live webcast and international dial-in provided for investors. The call is a routine investor-relations event in which management will review Q4 results and commentary on outlook; material market reaction would depend on the actual reported results and any guidance provided during the call.

Analysis

Market structure: A clean beat at CME (CME) would directly benefit exchanges, clearinghouses and data vendors (ICE, CME, market-data resellers) via higher transaction and recurring data revenue; traditional brokers and smaller regional venues are the losers if flow migrates to deep, liquid futures/clearing venues. Expect incremental pricing power in cleared products if daily average volume (ADV) growth >5% QoQ or open interest rises >10% YoY, allowing CME to push fee schedules or data-tier upsells.

Risk assessment: Near-term (days) the biggest risks are an operational outage or an earnings guidance miss; short-term (weeks) Fed rate surprises or a geopolitical shock can swing volumes by ±15–30%; long-term (6–24 months) regulatory action (position limits, margin changes) or new competitors in crypto/DEX derivatives are low-probability/high-impact tails. Hidden dependency: revenue mix—if non-transaction recurring data/licensing <30% of total, earnings are materially more cyclical and sensitive to volume shocks.

Trade implications: For earnings event trading, prefer defined-risk option structures to owning delta into elevated IV: establish a 3-month call spread on CME sized 1–1.5% of portfolio targeting 8–12% upside (buy ATM, sell 10–15% OTM) or, if IV <25%, buy a 1–2 week straddle sized 0.5% premium to capture a catalyst move; pair trade long CME vs short NDAQ (NDAQ) 1%/1% to express derivatives vs equity listing exposure. Rotate modestly into exchanges/clearing (CME, ICE) and trim retail brokers (SCHW) by 2–3% of risk budget; enter 2–5 days pre-call or wait 24–48 hours post-call to fade knee-jerk moves.

Contrarian angles: Consensus may underweight the durability of data/clearing annuity growth—if CME reports data revenue growth >10% YoY, the sell-off will likely be overdone and recover within 4–12 weeks as forward revenue visibility improves. Conversely, if ADV falls >8% QoQ despite benign macro, that would signal structural weakness and justify a larger short; monitor ADV, open interest, and data revenue trends over the next 30–90 days as the decisive metrics.

Key Decisions for Investors

• Establish a 1–1.5% portfolio long in CME via a 3-month call spread (buy ATM call, sell 10–15% OTM) ahead of the Feb 4 Q4 call to capture a potential 8–12% upside; size risk such that max premium loss = 0.5–1.5% of portfolio and cut if spread value falls 40%.
• Implement a 1%/1% pair trade: long CME equity (1% portfolio) and short NDAQ (1% portfolio) to express derivatives/data outperformance versus equity listing/data-only exposure; take profits if CME outperforms NDAQ by +5–8% within 6–12 weeks or stop-loss if underperforms by -6%.
• Volatility conditional: If implied vol into the call >30% (IV rank >70), sell a 2–3 week iron condor on CME sized to 0.5% portfolio premium with defined risk; if IV <25%, buy a 1–2 week straddle sized to 0.5% premium to capture a surprise move (stop-loss at 50% premium decay).
• Rotate sector weights: overweight exchanges/clearing (add 2–3% to positions in CME and ICE) and reduce retail broker exposure (trim SCHW/MS by 2–3% of risk) over the next 30 days; maintain the overweight only if CME’s data revenue grows >10% YoY or ADV growth >5% QoQ.